IBM's possible role with RDOC (scroll down for bold type):
from same SEC file: www4.edgar-online.com.
EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES
The names, ages and business backgrounds of the executive officers and
other significant employees of the Company who are not nominees for Director are
as follows:
MARK W. WINN, 47, has been Chief Financial Officer and Secretary of the
Company since September 1997. Mr. Winn served as the Senior Vice President and
Chief Financial Officer of Research Medical, Inc. (a manufacturer and developer
of specialty cardiovascular and pharmaceutical products) from November 1991 to
August 1997. Mr. Winn was the Vice President and Chief Financial Officer of Gory
Associated Industries (a South Florida building products manufacturer) from 1984
to 1991.
LELAND WITHERSPOON, 45, has been Vice President, Engineering since April
1997. Mr. Witherspoon was Director Product Research and Development for Sorin
Biomedicals, Inc. (a developer and manufacturer of cardiopulmonary and
cardiovascular products) from February 1992 to April 1997. He was Manager of
Research and Development for Pfizer/Shiley (a developer and manufacturer of
cardiopulmonary and cardiovascular equipment and disposables) from February 1992
to April 1997. Mr. Witherspoon held various technical and management positions
with Xerox Medical Systems (a manufacturer and developer of diagnostic medical
electronic and mechanical systems) from March 1979 to October 1990.
PETER KAZANZIDES, PH.D., 35, a co-founder of the Company, has been an
employee of the Company since November 1990 and Director of Robotics and
Software of the Company since December 1995. He received Sc.B., Sc.M., and Ph.D.
degrees in electrical engineering from Brown University in 1983, 1985, and 1988,
respectively. His dissertation focused on force control and multiprocessor
systems for robotics. He performed post-doctoral research in surgical robotics
from March 1989 to March 1990 at the IBM T.J. Watson Research Center.
BRENT D. MITTELSTADT, 38, a co-founder of the Company, has been an employee
of the Company since November 1990 and Director of Surgical Applications of the
Company since December 1995. He began research in surgical robotics in 1986 as a
visiting research scientist at the IBM T.J. Watson Research Center and is
responsible for much of the early development of CT guided robotic systems for
total hip replacement surgery.
HANS WEYENSCHENK, 47, has been Director of Marketing, Orthopaedics, of the
Company since February 1997. Prior thereto, he was employed by Vitatron Medical,
Inc., a wholly-owned subsidiary of Medtronics (a manufacturer of cardiac
products), as Director of Marketing, Communications and Services from 1996 to
February 1997 and Director of International Sales from 1987 to 1995.
JEROME LEBON, 42, has been Director of Marketing, Neurosurgery of the
Company since September 5, 1997. He was Executive Vice President of
International Sales of Innovative Medical Machines International, S.A. (a
manufacturer and distributor of neurosurgical products), which the Company
acquired in September 16
1997, from 1996 until September 1997. He was International Vice President of
Technomed International (a lithrotripsy company in France) from 1987 to 1995.
JEFFREY A. JOHNSON, 46, has been Director of Marketing, U.S.A. of the
Company since June 1997. Mr. Johnson was Marketing Manager for Sorin Biomedical,
Inc. (a developer and manufacturer of cardiopulmonary and cardiovascular
equipment) from 1992 to June 1997. Mr. Johnson was a Product Manager for the
Ultrasound division of Philips Medical Systems, Inc. from 1984 to 1991.
KENNETH M. SAN VINCENTE, 37, has been Director of Software Systems of the
Company since July 1997. Mr. San Vincente was Software Engineering Manager for
EndoSonics Corporation (a developer and manufacturer of intravascular ultrasound
equipment) from 1994 to June 1997 and a project engineering manager for the
Control Systems Division of Parker Hannifin Corporation from 1989 to 1993. |
